StreetAlpha.app
Home › Stocks › CERT

Certara, Inc. (CERT)

Healthcare
$11.06
▼ −2.90%
LAST CLOSE · NOV 17

Certara sells biosimulation software, regulatory writing tools, and consulting services that help drug developers and regulators make decisions. It last closed at $11.06 on Nov 17, down 2.90% on the day. The average 12-month price target from 3 analysts is $11.00 (-0.5% from the last close), with a high of $12.00 and a low of $10.00. Analyst consensus is Hold, based on the latest ratings from 3 firms (1 buy, 2 hold, 0 sell).

AI Auto Pilots
Is CERT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$425.8M
+13.3% vs a year ago
Net income
−$64.3M
−691.5% vs a year ago
EPS (diluted)
−$0.42
−700.0% vs a year ago
Free cash flow
$78.2M
18.4% margin
Valuation
Market cap
$1.7B
152.5M shares
P/E
–
No P/E while losing money
Price to sales
4.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$214.9M
At Sep 30
Debt
$291.2M
At Sep 30
Shareholder equity
$977.9M
Buybacks
$61.3M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $286.1M$286.1MFY2021FY2022: $335.6M$335.6MFY2022FY2023: $354.3M$354.3MFY2023FY2024: $385.1M$385.1MFY2024FY2025: $418.8M$418.8MFY2025

From CERT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Hold
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
3firms
1 Buy2 Hold0 Sell
Each firm's latest rating on CERT in the past 90 days
Average 12-month target
$11.00
▼ 0.5% downside

Based on 3 analysts who set a price target on CERT in the past 90 days. The average target is $11.00, with a high of $12.00 and a low of $10.00, compared with the last close of $11.06.

Low $10.00Avg $11.00High $12.00
Blue marker: last close $11.06
Highest target$12.00
Average target$11.00
Lowest target$10.00
Latest rating changes
BarclaysTarget raised
Nov 6Hold$9 → $12
TD CowenMaintained
Oct 13Buy$11
BarclaysTarget raised
Oct 7Hold$7.50 → $9
UBSDowngrade
Sep 30Hold$10
BarclaysMaintained
Aug 5Hold$7.50
DateFirmActionRatingPrice target
Nov 6BarclaysTarget raisedHold$9 → $12
Oct 13TD CowenMaintainedBuy$11
Oct 7BarclaysTarget raisedHold$7.50 → $9
Sep 30UBSDowngradeHold$10
Aug 5BarclaysMaintainedHold$7.50
Loading…

Technical Analysis

CERT · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 33% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 53). The nearest support is the Pivot S1 at $10.89, and the nearest resistance the Pivot at $11.22.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 5.2%/day
Key levels
$12.6152 week high+14.0%
$11.73Swing high (Oct 28)+6.1%
$11.39Pivot R1+3.0%
$11.2420 day average+1.6%
$11.22Pivot+1.4%
$11.06Last close
$10.89Pivot S1−1.5%
$10.46Swing low (Nov 3)−5.4%
$9.8350 day average−11.1%
$8.74100 day average−21.0%
$7.39200 day average−33.2%
$4.4552 week low−59.8%
Indicators
RSI (14)52.54Middle of its rangeNeutral
MACD0.52Below its signal lineBearish
Stochastic41.1Middle of its rangeNeutral
ADX (14)47.7Strong uptrend
Williams %R-72.1Oversold below −80, overbought above −20Neutral
CCI (20)2.8Oversold below −100, overbought above 100Neutral
Rate of change+1.8%Change over 10 sessionsBullish
ATR (14)$0.58Typical daily range, 5.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for CERT

What happened before

See how CERT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CERT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CERT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CERT in the last 90 days.

Loading…

See today’s whale options flow across the market →

CERT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●132 buying vs 119 selling
  • ●Held by funds +0.1 pts
  • ▲Funds holding +5
  • ▼Superinvestors: 0 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding248243+2.1%
In funds' top 1024−50.0%
Held by funds89.2%89.1%+0.1 pts
New / increased50 / 8256 / 90−9.6%
Reduced / sold out77 / 4269 / 70−14.4%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CERT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CERT is in one of them and how their past CERT trades turned out.

CERT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CERT in an article yet. Here's the latest on the wider market.

CERT Congress Trades

All congress trades →
Trades, 12 months
5
Buys
3
60%
Sells
1
20%
People
1
Last filed Sep 22
Who traded CERT · since 2026
Latest 5 filings
$1K – $15KTraded Aug 31, 2026Filed Sep 22, 2026
$15K – $50KTraded May 15, 2026Filed Jul 1, 2026
$15K – $50KTraded Mar 30, 2026Filed May 14, 2026
$15K – $50KTraded Feb 26, 2026Filed May 14, 2026
$15K – $50KTraded Jan 26, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchBuy$1K – $15KAug 31, 2026Sep 22, 202622 d
Donald J TrumpExecutive branchSell$15K – $50KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchBuy$15K – $50KMar 30, 2026May 14, 202645 d
Donald J TrumpExecutive branchOther$15K – $50KFeb 26, 2026May 14, 202677 d
Donald J TrumpExecutive branchBuy$15K – $50KJan 26, 2026May 14, 2026108 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Certara

Certara is based in Radnor, Pennsylvania, and provides biosimulation software, regulatory science tools, and consulting services for drug development. Its products include the Simcyp Simulator, which predicts how drugs behave in the body, and the Phoenix software for analyzing pharmacokinetic data. The company also offers CoAuthor software and related services to help draft regulatory submissions. Its customers include biopharmaceutical and biotech companies, academic institutions, and drug regulatory agencies.

Headquarters
Radnor, PA